View in EDS HTML Full Text PDF Full Text

JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes.

Saved in:
Bibliographic Details
Title: JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes.
Authors: Sureau L; CHU Angers, Laboratoire d'Hématologie, Angers, France.; Univ Angers, Nantes Université, CHU Angers, Inserm, CNRS, CRCI2NA, F-49000, Angers, France.; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France., Buors C; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France.; CHU Brest, Laboratoire d'Hématologie, Brest, France., Ianotto JC; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France.; CHU Brest, Service d'Hématologie Clinique, Brest, France., Boyer F; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France.; CHU Angers, Service des Maladies du Sang, Angers, France., Tanguy-Schmidt A; Univ Angers, Nantes Université, CHU Angers, Inserm, CNRS, CRCI2NA, F-49000, Angers, France.; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France.; CHU Angers, Service des Maladies du Sang, Angers, France., Roy L; Hôpital Universitaire Henri Mondor, Service Hématologie Clinique, APHP & UPEC, UFR de Santé, Créteil, France., Cayssials E; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France.; CHU Poitiers, Service d'Oncologie Hématologique et Thérapie Cellulaire, Poitiers, France., Cailly L; CHU Poitiers, Service d'Oncologie Hématologique et Thérapie Cellulaire, Poitiers, France., Chomel JC; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France.; CHU Poitiers, Service de Cancérologie Biologique, Poitiers, France., Chauveau A; CH de Cornouaille, Laboratoire d'Hématologie, Quimper, France., Orvain C; Univ Angers, Nantes Université, CHU Angers, Inserm, CNRS, CRCI2NA, F-49000, Angers, France.; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France.; CHU Angers, Service des Maladies du Sang, Angers, France., Mansier O; CHU de Bordeaux, Laboratoire d'Hématologie et Université de Bordeaux, Inserm U1034, Bordeaux, France., Ranta D; CHU Nancy, Hématologie Clinique, Nancy, France., Robles M; CH Périgueux, Hématologie Clinique, Périgueux, France., Gyan E; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France.; CHU Tours, Service d'Hématologie et Thérapie Cellulaire, CNRS EMR 7001 LNOx, université de Tours EA7501, Tours, France., Hérault O; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France.; CHU Tours, Service d'Hématologie Biologique, CNRS EMR 7001 LNOx, université de Tours EA7501, Tours, France., Nimubona S; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France.; CHU Rennes, Service d'Hématologie Clinique, Rennes, France., Marchand T; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France.; CHU Rennes, Service d'Hématologie Clinique, Rennes, France.; INSERM U1236, Faculté de Médecine, Université Rennes 1, Rennes, France., Lippert E; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France.; CHU Brest, Laboratoire d'Hématologie, Brest, France., Riou J; CHU Angers, Département de Biostatistiques et de Méthodologie, DRCI, Angers, France.; Univ Angers, CHU Angers, Inserm, CNRS, MINT, SFR ICAT, Angers, France., Ugo V; CHU Angers, Laboratoire d'Hématologie, Angers, France. valerie.ugo@chu-angers.fr.; Univ Angers, Nantes Université, CHU Angers, Inserm, CNRS, CRCI2NA, F-49000, Angers, France. valerie.ugo@chu-angers.fr.; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France. valerie.ugo@chu-angers.fr., Luque Paz D; CHU Angers, Laboratoire d'Hématologie, Angers, France. damien.luquepaz@chu-angers.fr.; Univ Angers, Nantes Université, CHU Angers, Inserm, CNRS, CRCI2NA, F-49000, Angers, France. damien.luquepaz@chu-angers.fr.; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France. damien.luquepaz@chu-angers.fr.
Source: Blood cancer journal [Blood Cancer J] 2022 Apr 08; Vol. 12 (4), pp. 56. Date of Electronic Publication: 2022 Apr 08.
Publication Type: Letter
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35395836
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sureau+L%22">Sureau L</searchLink>; CHU Angers, Laboratoire d'Hématologie, Angers, France.; Univ Angers, Nantes Université, CHU Angers, Inserm, CNRS, CRCI2NA, F-49000, Angers, France.; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France.<br /><searchLink fieldCode="AU" term="%22Buors+C%22">Buors C</searchLink>; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France.; CHU Brest, Laboratoire d'Hématologie, Brest, France.<br /><searchLink fieldCode="AU" term="%22Ianotto+JC%22">Ianotto JC</searchLink>; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France.; CHU Brest, Service d'Hématologie Clinique, Brest, France.<br /><searchLink fieldCode="AU" term="%22Boyer+F%22">Boyer F</searchLink>; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France.; CHU Angers, Service des Maladies du Sang, Angers, France.<br /><searchLink fieldCode="AU" term="%22Tanguy-Schmidt+A%22">Tanguy-Schmidt A</searchLink>; Univ Angers, Nantes Université, CHU Angers, Inserm, CNRS, CRCI2NA, F-49000, Angers, France.; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France.; CHU Angers, Service des Maladies du Sang, Angers, France.<br /><searchLink fieldCode="AU" term="%22Roy+L%22">Roy L</searchLink>; Hôpital Universitaire Henri Mondor, Service Hématologie Clinique, APHP & UPEC, UFR de Santé, Créteil, France.<br /><searchLink fieldCode="AU" term="%22Cayssials+E%22">Cayssials E</searchLink>; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France.; CHU Poitiers, Service d'Oncologie Hématologique et Thérapie Cellulaire, Poitiers, France.<br /><searchLink fieldCode="AU" term="%22Cailly+L%22">Cailly L</searchLink>; CHU Poitiers, Service d'Oncologie Hématologique et Thérapie Cellulaire, Poitiers, France.<br /><searchLink fieldCode="AU" term="%22Chomel+JC%22">Chomel JC</searchLink>; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France.; CHU Poitiers, Service de Cancérologie Biologique, Poitiers, France.<br /><searchLink fieldCode="AU" term="%22Chauveau+A%22">Chauveau A</searchLink>; CH de Cornouaille, Laboratoire d'Hématologie, Quimper, France.<br /><searchLink fieldCode="AU" term="%22Orvain+C%22">Orvain C</searchLink>; Univ Angers, Nantes Université, CHU Angers, Inserm, CNRS, CRCI2NA, F-49000, Angers, France.; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France.; CHU Angers, Service des Maladies du Sang, Angers, France.<br /><searchLink fieldCode="AU" term="%22Mansier+O%22">Mansier O</searchLink>; CHU de Bordeaux, Laboratoire d'Hématologie et Université de Bordeaux, Inserm U1034, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Ranta+D%22">Ranta D</searchLink>; CHU Nancy, Hématologie Clinique, Nancy, France.<br /><searchLink fieldCode="AU" term="%22Robles+M%22">Robles M</searchLink>; CH Périgueux, Hématologie Clinique, Périgueux, France.<br /><searchLink fieldCode="AU" term="%22Gyan+E%22">Gyan E</searchLink>; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France.; CHU Tours, Service d'Hématologie et Thérapie Cellulaire, CNRS EMR 7001 LNOx, université de Tours EA7501, Tours, France.<br /><searchLink fieldCode="AU" term="%22Hérault+O%22">Hérault O</searchLink>; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France.; CHU Tours, Service d'Hématologie Biologique, CNRS EMR 7001 LNOx, université de Tours EA7501, Tours, France.<br /><searchLink fieldCode="AU" term="%22Nimubona+S%22">Nimubona S</searchLink>; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France.; CHU Rennes, Service d'Hématologie Clinique, Rennes, France.<br /><searchLink fieldCode="AU" term="%22Marchand+T%22">Marchand T</searchLink>; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France.; CHU Rennes, Service d'Hématologie Clinique, Rennes, France.; INSERM U1236, Faculté de Médecine, Université Rennes 1, Rennes, France.<br /><searchLink fieldCode="AU" term="%22Lippert+E%22">Lippert E</searchLink>; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France.; CHU Brest, Laboratoire d'Hématologie, Brest, France.<br /><searchLink fieldCode="AU" term="%22Riou+J%22">Riou J</searchLink>; CHU Angers, Département de Biostatistiques et de Méthodologie, DRCI, Angers, France.; Univ Angers, CHU Angers, Inserm, CNRS, MINT, SFR ICAT, Angers, France.<br /><searchLink fieldCode="AU" term="%22Ugo+V%22">Ugo V</searchLink>; CHU Angers, Laboratoire d'Hématologie, Angers, France. valerie.ugo@chu-angers.fr.; Univ Angers, Nantes Université, CHU Angers, Inserm, CNRS, CRCI2NA, F-49000, Angers, France. valerie.ugo@chu-angers.fr.; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France. valerie.ugo@chu-angers.fr.<br /><searchLink fieldCode="AU" term="%22Luque+Paz+D%22">Luque Paz D</searchLink>; CHU Angers, Laboratoire d'Hématologie, Angers, France. damien.luquepaz@chu-angers.fr.; Univ Angers, Nantes Université, CHU Angers, Inserm, CNRS, CRCI2NA, F-49000, Angers, France. damien.luquepaz@chu-angers.fr.; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL), Angers, France. damien.luquepaz@chu-angers.fr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2022 Apr 08; Vol. 12 (4), pp. 56. <i>Date of Electronic Publication: </i>2022 Apr 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35395836
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-022-00646-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 56
    Titles:
      – TitleFull: JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sureau L
      – PersonEntity:
          Name:
            NameFull: Buors C
      – PersonEntity:
          Name:
            NameFull: Ianotto JC
      – PersonEntity:
          Name:
            NameFull: Boyer F
      – PersonEntity:
          Name:
            NameFull: Tanguy-Schmidt A
      – PersonEntity:
          Name:
            NameFull: Roy L
      – PersonEntity:
          Name:
            NameFull: Cayssials E
      – PersonEntity:
          Name:
            NameFull: Cailly L
      – PersonEntity:
          Name:
            NameFull: Chomel JC
      – PersonEntity:
          Name:
            NameFull: Chauveau A
      – PersonEntity:
          Name:
            NameFull: Orvain C
      – PersonEntity:
          Name:
            NameFull: Mansier O
      – PersonEntity:
          Name:
            NameFull: Ranta D
      – PersonEntity:
          Name:
            NameFull: Robles M
      – PersonEntity:
          Name:
            NameFull: Gyan E
      – PersonEntity:
          Name:
            NameFull: Hérault O
      – PersonEntity:
          Name:
            NameFull: Nimubona S
      – PersonEntity:
          Name:
            NameFull: Marchand T
      – PersonEntity:
          Name:
            NameFull: Lippert E
      – PersonEntity:
          Name:
            NameFull: Riou J
      – PersonEntity:
          Name:
            NameFull: Ugo V
      – PersonEntity:
          Name:
            NameFull: Luque Paz D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 04
              Text: 2022 Apr 08
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1